A Study of AT-02 in Subjects With Systemic Amyloidosis.
A Study of AT-02 in Subjects With Systemic Amyloidosis.
Active, not recruiting · NCT05951049 · Registry updated 2026-05-06Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Study of AT-02 in Subjects With Systemic Amyloidosis. | Immunoglobulin Light-chain Amyloidosis, Neoplasms by Histologic Type, Nutritional and Metabolic Diseases, amyloidosis, immune system disorder, immunoproliferative disorder, lymphoproliferative syndrome, metabolic disease, monoclonal gammopathy, neoplasm, plasma cell neoplasm, proteostasis deficiencies | Active, not recruiting | Phase 2 | 2026-05-06 | NCT05951049 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Attralus, Inc. | 3 |
| Novotech (Australia) Pty Limited | 15 |
4 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Cleveland Clinic | Cleveland | United States | 558 |
| Kansas City | Kansas City | United States | 1 |
| OHSU (Oregon Health & Science University) | Portland | United States | 1 |
| Penn Presbyterian Medical Center | Philadelphia | United States | 44 |